Enter your search term below:
Unproven Stem Cell Treatments: Law & Ethics Presented by the ANZ Legal & Regulatory Affairs (ANZ LRA) Committee & The Committee on the Ethics of Cell and Gene Therapy (ECGT) Although there are private stem cell clinics that promote the use...
Unproven Stem Cell Treatments - Law & Ethics Compressed.mp4
Particulates in Cell & Gene Therapy Products: A Survey and a Solution Presented by the ISCT Process Development and Manufacturing Committee Particulates are everywhere but do they pose a problem in cell and gene therapy products? Blood...
Particulates in Cell & Gene Therapy Products_ A survey and a solution.mp4
Challenges and Solutions in CGT Manufacturing Processes - Integration Between Manufacturing Data and Clinical Data Based Upon Automated Cell Culturing Systems Presented by the ISCT Asia Regional Executive Committees Part 2 of the ISCT Asia Webinar Series Sponsored in part by: Hitachi...
June 27 Asia Webinar_Edited.mp4
Commercial Development of CGTs in Korea: Bringing Novel Technologies to Therapeutic Reality Presented by the ISCT Asia Regional Executive Committees Part 1 of the ISCT Asia Webinar Series Webinar Description: Exploring novel technologies...
March Webinar Recording_Edited.mp4
Webinar Description: The cancer vaccine webinar by ISCT is devoted to individuals associated with cancer vaccines, immune effective therapy programs, GMP cell processing laboratories, regulatory, quality and other forms of cancer immunotherapy. Key Learning Objectives: To...
Cancer Vaccines for Oncological Therapy.mp4
Webinar Description: In the second half of 6-part Cold Chain Webinar Series, we will cover common solutions to issues encountered in logistics and supply of getting ATMPs to intended destinations and patients. Part 4 revisits formulation and container selection by addressing how these...
Webinar Description: Hundreds of institutions now have access to commercial CAR T cells, but in parallel many institutions globally are looking to implement a more decentralized approach using partnerships or commercially available vectors and devices. Here we describe what is required to...
GMT20220915-150104_Recording_gallery_1920x1080.mp4
Webinar Description: This webinar will discuss the specific characteristics and biologic activity of a specialized population of cells derived from the vascular endothelium. These cells produce signaling molecules that stimulate the intrinsic progenitor cells that are resident is many...
GMT20220331-163021_Recording_gallery_2844x1200.mp4
Reprogramming hiPSC and differentiation: Challenges in getting stable lines and good differentiating candidates for cell therapies explained. Produced by: ISCT Asia Regional Executive Committee Sponsored by: ...
ISCT Asia Regional Webinar I Reprogramming hiPSC and differentiation-20210326 0030-1.mp4
Webinar Description: Two speakers provide a comparative discussion on challenges in development and manufacturing for NK cell therapies. Our first speaker, based in the US, discusses the topic through examples of manufacturing for solid and hematological malignancies. Our second speaker brings...
3 attachments